Lv11
40 积分 2024-07-15 加入
How I treat refractory acute GVHD
13小时前
待确认
Dismal response to high-dose methylprednisolone after failure to respond to standard dose in patients with acute GVHD
4天前
已完结
Muromonab-CD3 (Orthoclone OKT3®), methylprednisolone and cyclosporine for acute graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation
4天前
已完结
Mismatched unrelated donors allogeneic hematopoietic stem cell transplantation with antithymocyte globulin for hematological malignancies: a multicenter retrospective study in China
8天前
已完结
JAK inhibitor selectivity: new opportunities, better drugs?
9天前
已完结
Ruxolitinib: Evolution or Revolution in Treatment of Patients with Polycythemia Vera?
9天前
已关闭
Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studies
9天前
已完结
Venetoclax in Combination with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia Is Comparable to Alternative Regimens
11天前
已关闭
Oral decitabine plus cedazuridine and venetoclax in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: a single-centre, phase 1/2 study
14天前
已完结
Azacitidine and venetoclax with or without pevonedistat in patients with newly diagnosed acute myeloid leukemia
14天前
已完结
皖公网安备34019202002308
